Table 2

Univariate analyses of predictors of delayed symptomatic intracranial haemorrhage (d-sICH)

No d-sICH
(n=1497)
d-sICH
(n=23)
P value
Age (median, IQR)78 (18)72 (15)0.081
Sex (% women)756 (50.5)6 (26.1)0.021
Hypertension (%)1239/1496 (82.8)18 (78.3)0.577
Diabetes (%)499/1495 (33.4)11 (47.8)0.181
Hyperlipidaemia (%)835/1496 (55.8)18 (78.3)0.034
Prior stroke or TIA (%)471/1496 (31.5)5 (21.7)0.373
Active smoking (%)179/1495 (12.0)4 (17.4)0.605
Congestive heart failure (%)364/1474 (24.7)7 (30.4)0.477
Coronary artery disease (%)466/1496 (31.1)10 (43.5)0.256
Peripheral vascular disease (5)99/1495 (6.6)1 (4.4)1.000
CHA2DS2Vasc score (median, IQR)5 (3)4 (4)0.876
Home statin (%)817/1495 (54.6)17 (73.9)0.090
Home anticoagulation (%)537/1495 (35.9)9 (39.1)0.827
Systolic blood pressure (median, IQR)148 (34)143 (28)0.099
Diastolic blood pressure (median, IQR)80 (21)79 (20)0.813
NIHSS score (median, IQR)8 (12)16 (14)0.073
Glucose (median, IQR)121 (45)129 (70)0.962
Low-density lipoprotein (median, IQR)77 (44)75 (36)0.889
Platelet count (median, IQR)205 (84)204 (77)0.964
Alteplase (%)434 (29.0)3 (13.0)0.107
Thrombectomy (%)377 (25.2%)8 (34.8)0.333
Ischaemic stroke >10 mL (%)808/1380 (57.9)19 (82.6)0.019
Posterior circulation location (%)251/1429 (17.6)5 (21.7)0.582
Early haemorrhagic transformation (%)255/1497 (17.0)14 (60.9)<0.001
Anticoagulation initiated (%)1278/1493 (85.6)22 (95.7)0.235
Time to initiating anticoagulation in days (median, IQR)4 (8)6 (13)0.133
  • CHA2DS2VASc, Congestive heart failure, Hypertension, Age, Diabetes, Stroke, and Vascular Disease and Sex categories.